专利 等待形式审查

PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE

Overview

LaoBiz.com profiles the Laos Patent “PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE” from open registry fields, filed by CHONG KUN DANG PHARMACEUTICAL CORP. on 2016-08-24; current status: Awaiting formal examination. Identifiers include application No. P/581; DIP id LAP581; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-16. Classification: A61K 31/155、A61K 31/426、A61K 31/506、A61K 47/38、A61K 9/28. Inventor(s)/designer(s): CHO, Min Kwan, LIM, Jong Lae, PARK, Shin Jung, SHIN, Eun Ji, SHIN, Teak Hwan. Abstract hint: The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobegl…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.

专利 老挝 DIP

申请号 P/581
申请日期 2016-08-24
申请人 CHONG KUN DANG PHARMACEUTICAL CORP.
代理机构 CONCETTI-LAO CO., LTD
类别 A61K 31/155 · A61K 31/426 · A61K 31/506 · A61K 47/38 · A61K 9/28

图样

下载

基础信息

类型
专利
申请号
P/581
状态
等待形式审查
申请人
CHONG KUN DANG PHARMACEUTICAL CORP.
代理机构
CONCETTI-LAO CO., LTD
申请日期
2016-08-24
公开/公告日
2026-01-16
国际分类
A61K 31/155 · A61K 31/426 · A61K 31/506 · A61K 47/38 · A61K 9/28
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz.com 企业数据库联动

摘要

The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.

The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.

LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP581.html) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP581.html) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz.com

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。